PMID: 11920535Mar 29, 2002Paper

European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease

Cancer
Richard B WilderJ D Cox

Abstract

Lymphocyte-predominant Hodgkin disease (LPHD) is rare and has a natural history different from that of classic Hodgkin disease. There is little information in the literature regarding the role of chemotherapy in patients with early-stage LPHD. The objective of this study was to examine recurrence free survival (RFS), overall survival (OS), and patterns of first recurrence in patients with LPHD who were treated with radiotherapy alone or with chemotherapy followed by radiotherapy. From 1963 to 1996, 48 consecutive patients ages 16-49 years (median, 28 years) with Ann Arbor Stage I (n = 30 patients) or Stage II (n = 18 patients), very favorable (VF; n = 5 patients) or favorable (F; n = 43 patients) LPHD, according to the European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte (EORTC-GELA) criteria, received radiotherapy alone (n = 37 patients) or received chemotherapy followed by radiotherapy (n = 11 patients). The percentages of patients with VF disease (11% vs. 9% in the radiotherapy group vs. the chemotherapy plus radiotherapy group, respectively) or F disease (89% vs. 91%, respectively) within the two treatment groups were similar (P = 1.00). A median of three cycles of chemothe...Continue Reading

References

Jan 1, 1977·British Journal of Haematology·J Palek
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M K GospodarowiczT Chua
Feb 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P MauchM Jochelson
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A Borg-GrechM Harris
Jan 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M H LeibenhautS A Rosenberg
Apr 1, 1988·International Journal of Radiation Oncology, Biology, Physics·L M FullerF Cabanillas
Jan 28, 1988·The New England Journal of Medicine·D P RegulaL M Weiss
Jan 1, 1984·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K J RussellH S Kaplan
May 1, 1982·Cancer·T V ColbyR A Warnke
Jan 15, 1995·International Journal of Radiation Oncology, Biology, Physics·E CrennanG Quong
Feb 1, 1993·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A RodriguezF Swan
Jul 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V I PappaT A Lister
Sep 19, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S BodisP M Mauch
Aug 1, 1997·International Journal of Radiation Oncology, Biology, Physics·K SasaiM Hiraoka
Feb 25, 1999·International Journal of Radiation Oncology, Biology, Physics·C S HaJ D Cox
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A WirthK Liew
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K H BackstrandP M Mauch

❮ Previous
Next ❯

Citations

Sep 5, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Irina V BalyasnikovaMaciej S Lesniak
Oct 4, 2002·Hematological Oncology
Mar 1, 2006·Current Hematologic Malignancy Reports·Lucia NogovàUNKNOWN German Hodgkin Study Group
May 23, 2012·Bioconjugate Chemistry·Jangwook LeeKuen Yong Lee
Jan 6, 2010·Journal of the American Chemical Society·Joseph C GenereuxJacqueline K Barton
Mar 3, 2010·Journal of the American Chemical Society·Ken-ichi ShinoharaHiroshi Sugiyama
Feb 15, 2012·Journal of Agricultural and Food Chemistry·Yong Hua QiJian Ping Wang
Oct 11, 2013·Journal of Proteome Research·Sadr-ul ShaheedChris W Sutton
Jul 2, 2003·Nature Reviews. Cancer·Jasti S Rao
Sep 3, 2003·Nature Reviews. Cancer·Mark E Dudley, Steven A Rosenberg
Feb 18, 2004·Nature Reviews. Cancer·Hua Yu, Richard Jove
Jul 2, 2004·Nature Reviews. Cancer·Bryan P Toole
Sep 3, 2004·Nature Reviews. Cancer·Steven A Belinsky
Nov 2, 2004·Nature Reviews. Cancer·Robert A Gatenby, Robert J Gillies
Dec 2, 2004·Nature Reviews. Cancer·Jean-Pierre Issa
Feb 3, 2005·Nature Reviews. Cancer·Michael A Dyer, Rod Bremner
Mar 2, 2005·Nature Reviews. Cancer·Jeffrey E Green, Tamaro Hudson
Jul 22, 2005·Nature Reviews. Cancer·Andrew J G SimpsonLloyd J Old
Sep 9, 2005·Nature Reviews. Cancer·Yasuko KondoSeiji Kondo
Aug 20, 2005·Nature Reviews. Cancer·Xue-Ru Wu
Dec 6, 2005·Nature Reviews. Cancer·Eyal Gottlieb, Ian P M Tomlinson
Oct 22, 2005·Nature Reviews. Cancer·Joseph A Ludwig, John N Weinstein
Dec 13, 2005·Nature Reviews. Cancer·Marie-France DemierreScott M Lippman
Dec 24, 2005·Nature Reviews. Cancer·Benjamin D Rowland, Daniel S Peeper
Feb 24, 2006·Nature Reviews. Cancer·Cornelia M UlrichJohn D Potter
Mar 17, 2006·Nature Reviews. Cancer·Paul A Khavari
May 26, 2006·Nature Reviews. Cancer·Angelo L VescoviBrent A Reynolds
Jul 25, 2006·Nature Reviews. Cancer·Carla Boccaccio, Paolo M Comoglio
Dec 23, 2006·Nature Reviews. Cancer·Ciaran B J WoodmanLawrence S Young
Jan 16, 2007·Nature Reviews. Cancer·Adriana Albini, Michael B Sporn
Jan 26, 2007·Nature Reviews. Cancer·Robert T Dorsam, J Silvio Gutkind
Jul 25, 2007·Nature Reviews. Cancer·Teru HideshimaKenneth C Anderson
Aug 10, 2007·Nature Reviews. Cancer·Kristopher K Frese, David A Tuveson
Sep 25, 2007·Nature Reviews. Cancer·Erik Sahai
Jan 19, 2008·Nature Reviews. Cancer·Kevin Brindle
Jan 26, 2008·Nature Reviews. Cancer·Jason RiceFreda K Stevenson
Mar 25, 2009·Nature Reviews. Cancer·Bethan Psaila, David Lyden
May 15, 2009·Nature Reviews. Cancer·Tarek Abbas, Anindya Dutta
Oct 24, 2009·Nature Reviews. Cancer·Maria Mancini, Alex Toker
Dec 24, 2009·Nature Reviews. Cancer·Jay S Desgrosellier, David A Cheresh
Jan 23, 2010·Nature Reviews. Cancer·Juan-Manuel SchvartzmanRobert Benezra
Feb 20, 2010·Nature Reviews. Cancer·Dingzhi Wang, Raymond N Dubois

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.